Product Images Wellbutrin SR

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Wellbutrin SR NDC 0173-0135 by Glaxosmithkline Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

00173 0135 55 splimage30 e718f397

00173 0135 55 splimage30 e718f397

00173 0722 00 splimage30 f918fcf7

00173 0722 00 splimage30 f918fcf7

Not available. The given text appears to be a list of numbers without any further context. It does not provide any information to generate a useful description.*

00173 0947 55 splimage30 b818dc56

00173 0947 55 splimage30 b818dc56

buproprion hydrochloride chemical structure - wellbutrinsr spl graphic 01

buproprion hydrochloride chemical structure - wellbutrinsr spl graphic 01

Wellbutrin SR 100 mg 60 count label - wellbutrinsr spl graphic 02

Wellbutrin SR 100 mg 60 count label - wellbutrinsr spl graphic 02

Wellbutrin SR is a medication that comes in sustained-release tablet form with 100mg of bupropion HCI. It should not be used with any other medicine that contains bupropion HCI, and it is required by federal law that it comes with a Medication Guide. The prescribing information can be found on a website with the code 805306. The tablets should be stored at a controlled temperature between 68°F to 77°F (20°C to 25°C). The bottle contains 60 tablets and was manufactured by GSK, with a code of ATPNCZ7708. The product was made in Spain, with a code of C20196K and an expiration date of 7719.*

Wellbutrin SR 150 mg 60 count label - wellbutrinsr spl graphic 03

Wellbutrin SR 150 mg 60 count label - wellbutrinsr spl graphic 03

Twice-A-Day is a medication called Wellbutrin SR that warns against taking with other bupropion-containing drugs. Each tablet contains 150 mg of bupropion HCL. Federal law mandates the medication guide should be provided with each bottle of Wellbutrin SR. The description also notes to keep the medication out of light. Finally, a trademark called GloSnitidine is mentioned as being owned by GSK and licensed in Spain, with a batch number and revision date provided.*

Wellbutrin SR 200 mg 60 count label - wellbutrinsr spl graphic 04

Wellbutrin SR 200 mg 60 count label - wellbutrinsr spl graphic 04

Wellbutrin SR is a medication available in a sustained-release tablet form. Each tablet contains 200mg of bupropion HCL. However, it is imperative not to use it with other drugs that contain bupropion HCL. Federal law requires the medication guide to be provided with this bottle of Wellbutrin SR. It's important to store the medication at a controlled room temperature, i.e., at 68°F to 77°F (20°C to 25°), and to keep it out of reach of children. Unfortunately, the rest of the text is not legible.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.